Etarfolatide
Sponsors
Endocyte
Conditions
Adenocarcinoma of the LungBreast Neoplasms
Phase 2
Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)
CompletedNCT00511485
Start: 2007-08-31End: 2009-11-30Updated: 2015-02-27
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)
WithdrawnNCT01953536
Start: 2014-04-30End: 2016-11-30Updated: 2014-12-19